BIONET Corp.
1784
Rank in Stocks
#21223
Established in 1989 and headquartered in Taipei City, Taiwan, BIONET Corp. is a... Established in 1989 and headquartered in Taipei City, Taiwan, BIONET Corp. is a global leader in umbilical cord blood preservation, serving clients across Taiwan and internationally. The company provides a comprehensive suite of stem cell banking services, encompassing the storage of general stem cells, mesenchymal stem cells, dental stem cells, adipose stem cells, and peripheral blood stem cells combined with immune cells. Beyond its core stem cell preservation, BIONET also conducts genetic testing services. Its product offerings further extend to anti-aging solutions leveraging stem cell technology, alongside its unique ANIKINE series. Additionally, the company is a pioneer in offering Exosome, an innovative cell-free therapeutic approach.
Share Price
$1.43
Last synced: 2026-11-10
Market Cap
$71.47M
Change (1 day)
1.18%
Change (1 year)
-52.71%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade BIONET Corp. (1784)
Category
Healthcare
Operating Margin for BIONET Corp. (1784)
Operating Margin as of November 2026 TTM: -0.59%
According to BIONET Corp.'s latest financial reports, its current operating margin (TTM) is -0.59%. At the end of 2025 the company had an operating margin of -1.17%.
Operating Margin history for BIONET Corp. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -0.59% | -49.57% |
| 2025 | -1.17% | -122.90% |
| 2024 | 5.11% | -31.96% |
| 2023 | 7.51% | -0.53% |
| 2022 | 7.55% | 65.93% |
| 2021 | 4.55% | 384.04% |
| 2020 | 0.94% | -11.32% |
| 2019 | 1.06% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -165.41% |
US
|
|
| -149.01% | 152.56% |
US
|
|
| 25.57% | -143.34% |
AU
|
|
| 31.23% | -152.93% |
BE
|
|
| 29.35% | -149.75% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about BIONET Corp.'s operating margin
What is BIONET Corp.'s operating margin?
BIONET Corp.'s operating margin is -0.59%, as of Nov 2026.
What was BIONET Corp.'s operating margin in 2025?
In 2025, BIONET Corp.'s operating margin was -1.17%, compared with 5.11% in 2024.
How has BIONET Corp.'s operating margin changed since 2020?
From 2020 to 2025, BIONET Corp.'s operating margin was highest in 2022 (7.55%) and lowest in 2025 (-1.17%).
How does BIONET Corp.'s operating margin compare with similar companies?
BIONET Corp.'s operating margin (-0.59%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.